The paper's citation list
No.The paper's citation list
1The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies. 2019;33:863 doi: 10.1038/s41375-018-0362-z
2The overexpression of IGF-1 is a poor prognostic factor in multiple myeloma. 2019;18:42 doi: 10.17650/1726-9784-2019-18-1-42-49
3The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond. 2019;17:100253 doi: 10.1016/j.jbo.2019.100253
4Anti-BCMA immunotoxins produce durable complete remissions in two mouse myeloma models. 2019;116:4592 doi: 10.1073/pnas.1821733116
5Multiple Myeloma: Available Therapies and Causes of Drug Resistance. 2020;12:407 doi: 10.3390/cancers12020407